Form 4: Danaher Executive VP Joakim Weidemanis Exercises and Sells Stock Options
SEC Form 4
Executive Vice President Joakim Weidemanis of Danaher Corp. exercised stock options and sold the acquired shares on April 25, 2024.
Summary
- On April 25, 2024, Joakim Weidemanis, an Executive Vice President at Danaher Corp, exercised employee stock options to acquire 22,433 shares of common stock at a price of $58.48 per share.
- Simultaneously, Weidemanis sold 22,433 shares of Danaher common stock at a price of $250.46 per share.
- Following these transactions, Weidemanis directly owns 90,412 shares of Danaher common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction. There is no indication of positive or negative implications for the company.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives who receive stock options as part of their compensation. It provides transparency into the trading activities of company insiders.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- The vesting schedule of these options (one-third each year for three years) is a standard practice to incentivize long-term commitment.
- Similar transactions are regularly reported by executives at comparable companies in the industrial and healthcare sectors, such as Siemens, Roche, and Abbott.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it is a routine insider transaction.
- The sale of shares by an executive could be perceived negatively if it were a large-scale or unexpected event, but this appears to be a standard exercise and sale of options.
Key Dates
| Date | Description |
|---|---|
| 02/24/2015 | Grant date of the employee stock options, which vest in three equal installments on the third, fourth, and fifth anniversaries. |
| 02/24/2025 | Expiration date of the employee stock options. |
| 04/25/2024 | Date of the transaction where stock options were exercised and shares were sold. |
| 04/26/2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.